Impact of factor VIII deficiency on clotting factor utilization in the United States

Autor: Aledort, Louis M., Goodnight, Scott H., Rao, A. Vuaya, Schwarz, Jan, Whitehurst, Deborah, Shapiro, Sandor S.
Zdroj: International Journal of Clinical & Laboratory Research; January 1983, Vol. 13 Issue: 1 p33-41, 9p
Abstrakt: In a study of 1,551 hemophiliacs over a 4-year period of time, factor VIII utilization was assessed. It is clear that factor VIII usage is a function of severity of disease and therapeutic program. The average amount of factor VIII used per patient was 39.880U/year. Patients seiected for home care, use significantly more than those patients not on home care. As much as 101,000 U/year are used by a small number of patients on prophylaxis. These data can be used in predicting source plasma requirements for annual national use as well as costs.
Databáze: Supplemental Index